These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 33985510)
1. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia. Shi L; Huang R; Lai Y BMC Med Genomics; 2021 May; 14(1):127. PubMed ID: 33985510 [TBL] [Abstract][Full Text] [Related]
2. Analysis of prognostic biomarker models of TXNIP/NLRP3/IL1B inflammasome pathway in patients with acute myeloid leukemia. Chen J; Hou Q; Chang T; Zheng J; Yao C; He J; Chen S; Wu X; Jin Z Int J Med Sci; 2024; 21(8):1438-1446. PubMed ID: 38903927 [No Abstract] [Full Text] [Related]
3. FAM213A is linked to prognostic significance in acute myeloid leukemia through regulation of oxidative stress and myelopoiesis. Oh CK; Ha M; Han ME; Heo HJ; Myung K; Lee Y; Oh SO; Kim YH Hematol Oncol; 2020 Aug; 38(3):381-389. PubMed ID: 32124993 [TBL] [Abstract][Full Text] [Related]
4. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia. Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187 [TBL] [Abstract][Full Text] [Related]
5. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset. Huang R; Liao X; Wang X; Li Q J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013 [No Abstract] [Full Text] [Related]
7. Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis. Ha M; Han ME; Kim JY; Jeong DC; Oh SO; Kim YH J Cell Biochem; 2019 Mar; 120(3):3672-3678. PubMed ID: 30203488 [TBL] [Abstract][Full Text] [Related]
8. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients. Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia. Park S; Kim YJ; Huh HJ; Chung HS; Lee M; Park YM; Mun YC; Seong CM; Huh J Hematology; 2021 Dec; 26(1):904-913. PubMed ID: 34789078 [TBL] [Abstract][Full Text] [Related]
10. Bai H; Zhou M; Zeng M; Han L DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754 [TBL] [Abstract][Full Text] [Related]
11. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000 [TBL] [Abstract][Full Text] [Related]
12. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia. Huang R; Liao X; Li Q Onco Targets Ther; 2017; 10():5243-5254. PubMed ID: 29138577 [TBL] [Abstract][Full Text] [Related]
13. High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia. Yu X; Chen C; Hu Y; Li K; Zhang Y; Chen Z; Nie D; Gao R; Huang Y; Zhong M; Wang C; Wang S; Zeng Y; Li Y; Zeng C Cancer Med; 2023 Apr; 12(7):9055-9067. PubMed ID: 36708053 [TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia. Lin MS; Zhong HY; Yim RL; Chen QY; Du HL; He HQ; Lin K; Zhao P; Gao R; Gao F; Zhang MY BMC Cancer; 2022 Oct; 22(1):1068. PubMed ID: 36243694 [TBL] [Abstract][Full Text] [Related]
15. Prognostic role of chemokine-related genes in acute myeloid leukemia. Hou Y; Chen Y; Zhang Y; Li M; Chen J PeerJ; 2024; 12():e17862. PubMed ID: 39135956 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients. Shi H; Gao L; Zhang W; Jiang M BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240 [TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia. Fu L; Shi J; Hu K; Wang J; Wang W; Ke X Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238 [TBL] [Abstract][Full Text] [Related]
18. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia. Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328 [TBL] [Abstract][Full Text] [Related]
19. Novel prognostic genes and subclasses of acute myeloid leukemia revealed by survival analysis of gene expression data. Lai Y; OuYang G; Sheng L; Zhang Y; Lai B; Zhou M BMC Med Genomics; 2021 Feb; 14(1):39. PubMed ID: 33536020 [TBL] [Abstract][Full Text] [Related]
20. NAD metabolism-related genes provide prognostic value and potential therapeutic insights for acute myeloid leukemia. Cao Y; Shu W; Jin P; Li J; Zhu H; Chen X; Zhu Y; Huang X; Cheng W; Shen Y Front Immunol; 2024; 15():1417398. PubMed ID: 38966636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]